Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Collaboration for Research in Intensive Care, Copenhagen, Denmark.
Acta Anaesthesiol Scand. 2021 Jul;65(6):792-800. doi: 10.1111/aas.13805. Epub 2021 Mar 15.
In previous studies of predictors of gastrointestinal (GI) bleeding in the intensive care unit (ICU), most patients received pharmacological stress ulcer prophylaxis (SUP). We aimed to assess associations between potential predictors of clinically important GI bleeding (CIB) and overt GI bleeding in adult ICU patients, while considering the effect and potential interaction with use of SUP.
We included 3291 acutely admitted adult ICU patients with risk factors for GI bleeding randomized to SUP (pantoprazole) or placebo in the SUP-ICU trial. We used logistic regression models adjusted for allocation to SUP to estimate associations between 23 potential predictors and CIB (primary outcome) and overt GI bleeding (secondary outcome). Furthermore, we assessed associations between potential predictors and both outcomes in each allocation group and assessed potential interaction with allocation to SUP.
Increasing SAPS II and SOFA scores, use of circulatory support and renal replacement therapy were associated with increased risk of CIB and overt GI bleeding; chronic lung disease was associated with increased risk of overt GI bleeding. Results for the remaining potential predictors were compatible with both no difference or increased and decreased risks. We found no strong evidence for any interaction between treatment allocation and any potential predictors.
In adult ICU patients at risk of GI bleeding, severity of illness, use of circulatory support and renal replacement therapy were associated with higher odds of CIB, with no strong evidence of interaction with SUP.
在之前的 ICU 胃肠道(GI)出血预测因素研究中,大多数患者接受了药物性应激性溃疡预防(SUP)。我们旨在评估潜在的 GI 出血(CIB)预测因素与成年 ICU 患者显性 GI 出血之间的相关性,同时考虑 SUP 的作用及其潜在的相互作用。
我们纳入了 3291 名患有 GI 出血风险因素的急性入住 ICU 的成年患者,他们在 SUP-ICU 试验中被随机分配到 SUP(泮托拉唑)或安慰剂组。我们使用调整了 SUP 分配的逻辑回归模型来估计 23 个潜在预测因素与 CIB(主要结局)和显性 GI 出血(次要结局)之间的相关性。此外,我们评估了每个分配组中潜在预测因素与两个结局之间的相关性,并评估了与 SUP 分配的潜在相互作用。
增加 SAPS II 和 SOFA 评分、使用循环支持和肾脏替代治疗与 CIB 和显性 GI 出血的风险增加相关;慢性肺部疾病与显性 GI 出血的风险增加相关。其余潜在预测因素的结果与无差异或增加和降低风险兼容。我们没有发现治疗分配与任何潜在预测因素之间存在强烈相互作用的证据。
在有 GI 出血风险的成年 ICU 患者中,疾病严重程度、循环支持和肾脏替代治疗的使用与 CIB 的可能性增加相关,与 SUP 之间没有强烈的相互作用证据。